U.S. drugmaker Perrigo Company has agreed to buy Irish Elan $ 8.6 billion, an agreement designed to expand overseas markets and reduce their tax bill.
Headquartered in Michigan, Perrigo said the company will support Fu Yilong investors $ 6.25 per share in cash and $ 10.25 Perrigo's stock. The deal's closing price on behalf of Elan's 11% premium on Friday.
Earlier this month, Elan said that the fight against malicious, lower-priced bid Royal Pharmaceutical spending a few months later, it is open to offer.
Perrigo Company said on Monday that it will become the Irish company says it can reduce by nearly half the annual savings of more than $ 150 million in tax liabilities.
About 700 of the U.S. company headquartered in Ireland to pay the profits tax rate of 12.5%??, compared to 35% of U.S. interest rates.
Elan confirmed the deal.
 



Other News:
Perrigo to buy Elan for $8.6B, seeks tax savings
Naming mediator brings authority to fractious Detroit bankruptcy case
Ex-Prime Minister Keita holds wide lead in Mali vote
Macau aims for another Vegas staple: boxing
Israeli-Palestinian peace talks to resume after three years
Taliban gunmen storm Pakistan prison, free hundreds
$53 million in jewels stolen in Cannes
Tunisian opposition may set up rival 'salvation government'